Furthermore, exenatide reduced HF-induced FTO gene levelsand reversed the changes in MDA and SOD in the NAFLD animal model, which in turninhibited the development of NAFLD. This evidence concerns the gene FTO and metabolic dysfunction-associated steatotic liver disease.